An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer

Rocio Garcia-Carbonero, Fernando Rivera, Joan Maurel, Jean Pierre M. Ayoub, Malcolm J. Moore, Andres Cervantes, Timothy R. Asmis, Jonathan D. Schwartz, Federico Nasroulah, Shaila Ballal, Josep Tabernero

Research output: Contribution to journalArticleResearchpeer-review

48 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences